After EMPA-REG: Docs Dissect Diabetes Study, Discuss ImplicationsAfter EMPA-REG: Docs Dissect Diabetes Study, Discuss Implications

Doctors tried to make sense of the "unique" finding of the EMPA-REG OUTCOME study, which showed a mortality benefit for empagliflozin, but admitted the trial posed more questions than it answered. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news